Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",27955,108,1.11 [0.71-1.74],0.6549034246506732
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",28540,146,0.69 [0.47-1.01],0.0549735161265529
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",28285,1026,0.78 [0.67-0.90],0.000678499817319
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Candidiasis,28573,309,0.81 [0.62-1.05],0.1112710698200235
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,27771,2818,0.84 [0.77-0.92],0.0001175871336482
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),28022,2120,0.80 [0.72-0.88],1.1543576326074124e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,28357,1019,0.83 [0.71-0.96],0.0119048969458255
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,28485,43,0.74 [0.37-1.49],0.398506303350254
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,27286,657,0.77 [0.64-0.93],0.0058872242514973
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,26379,632,0.60 [0.50-0.72],4.46706512429135e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,26628,174,0.75 [0.53-1.07],0.1084597460940043
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,21287,1232,0.80 [0.70-0.91],0.0009289224040911
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,26383,288,0.69 [0.52-0.90],0.0072383181644598
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,28524,1186,0.78 [0.68-0.90],0.0004505924750927
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Mycoses,28635,371,0.82 [0.64-1.04],0.104141200152458
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,27882,623,0.76 [0.63-0.92],0.0039316929774157
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,28573,726,0.81 [0.68-0.96],0.0172985577754889
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,27486,148,0.66 [0.45-0.96],0.0313152755737943
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,28677,33,1.30 [0.57-2.95],0.5266953420084166
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other septicaemia,28482,635,0.79 [0.65-0.95],0.0108016628547622
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,28516,74,0.90 [0.52-1.56],0.7167806018221607
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other viral diseases,28579,175,0.80 [0.56-1.14],0.2165556896063039
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",28564,160,0.80 [0.55-1.16],0.2409319469910994
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,27603,344,0.81 [0.63-1.04],0.1044354016939685
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,27508,249,0.59 [0.44-0.80],0.0004752406421408
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,27420,82,0.47 [0.29-0.77],0.0025576184986594
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,28649,54,1.27 [0.68-2.39],0.4552191471170851
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,28614,130,0.56 [0.38-0.84],0.0044796854396069
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Viral warts,28528,44,0.44 [0.23-0.85],0.0146801745050349
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],28535,51,0.47 [0.25-0.87],0.0165530258390928
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign lipomatous neoplasm,28378,328,0.91 [0.70-1.18],0.4911495838260507
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,28583,78,1.10 [0.64-1.88],0.7340597471631696
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,28562,83,0.94 [0.56-1.59],0.826425349651456
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,12802,45,1.49 [0.74-3.03],0.2653888273579129
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",28479,1216,0.91 [0.80-1.04],0.1774027823282578
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm of meninges,28665,51,0.68 [0.35-1.30],0.2441913438717007
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,28641,53,1.00 [0.52-1.91],0.9971025516373184
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,28655,96,0.95 [0.59-1.54],0.8330209520008254
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm of ovary,15811,101,0.73 [0.46-1.16],0.1826089179989188
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm: Ascending colon,28670,285,0.91 [0.69-1.20],0.5014789965391449
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm: Caecum,28667,210,1.01 [0.73-1.39],0.96834746951478
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",28607,61,0.50 [0.28-0.89],0.0174358062458705
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm: Descending colon,28669,182,0.97 [0.68-1.37],0.8473682579657349
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm: Rectum,28631,301,0.92 [0.70-1.20],0.5229909752812574
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,28602,558,0.88 [0.72-1.08],0.2205486340553397
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm: Transverse colon,28671,323,0.78 [0.60-1.01],0.0547981746311521
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Carcinoma in situ of breast,13604,89,0.55 [0.34-0.89],0.0151910206774144
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",13652,101,0.50 [0.32-0.78],0.0020524513731858
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",24785,31,1.44 [0.62-3.36],0.3988343911573507
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",24794,40,0.55 [0.27-1.12],0.0977346188961476
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",28633,113,0.92 [0.59-1.44],0.7233841150140137
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Haemangioma, any site",28633,111,0.93 [0.60-1.45],0.7511785351413881
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Leiomyoma of uterus,15157,428,1.07 [0.85-1.35],0.575958818797044
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Lung cancer and mesothelioma,21303,181,0.54 [0.39-0.75],0.0002316688640445
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Lymphoid leukaemia,24783,29,0.70 [0.30-1.63],0.4082520043759026
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",24906,152,1.33 [0.90-1.96],0.1559120702348078
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",24840,86,1.21 [0.73-2.01],0.4579837628232112
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",13708,85,1.05 [0.63-1.76],0.8551931739211451
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",24807,53,1.50 [0.78-2.88],0.2231543130603494
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",24823,69,0.75 [0.42-1.32],0.3133226784164002
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",24827,73,0.86 [0.50-1.48],0.5863884807920472
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",13680,57,1.01 [0.53-1.89],0.9871313013203976
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",24813,59,0.95 [0.52-1.76],0.8773488129951641
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",11557,426,1.05 [0.83-1.31],0.6997578466254164
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",24847,93,0.74 [0.46-1.19],0.21681494058672
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",24811,57,0.78 [0.42-1.46],0.4404462301494518
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,24821,67,1.38 [0.77-2.47],0.2843694635731649
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Melanocytic naevi,28429,220,1.04 [0.75-1.43],0.8301836888821128
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Melanocytic naevi of trunk,28625,98,1.05 [0.65-1.70],0.8376859380717704
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Melanoma in situ,24769,52,0.88 [0.45-1.69],0.6926776338872416
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",24816,62,0.70 [0.39-1.25],0.2275289770139183
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",24879,125,0.87 [0.57-1.32],0.5117726146450496
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",24876,122,0.59 [0.40-0.87],0.0080186192966277
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",24825,71,0.95 [0.54-1.66],0.8587687050267927
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Other benign neoplasms of skin,28487,143,0.94 [0.63-1.39],0.7494165334713854
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",25421,667,1.10 [0.92-1.33],0.2941815911623424
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",25454,700,1.15 [0.96-1.37],0.1404326005764563
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,28397,293,1.01 [0.76-1.32],0.9712143300489668
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,27205,56,0.74 [0.39-1.38],0.3420694408604555
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,28176,72,1.26 [0.72-2.21],0.4104466490344186
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,27848,2301,0.84 [0.77-0.93],0.0007857178138368
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,27449,25,0.46 [0.19-1.13],0.0913148364220885
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,28314,37,1.96 [0.91-4.20],0.0852582804653331
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,28217,1068,0.75 [0.65-0.87],9.833295740115298e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,28217,1068,0.75 [0.65-0.87],9.833295740115298e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,27209,60,0.82 [0.45-1.49],0.5084174320010353
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,28383,959,0.81 [0.70-0.94],0.0070047084017726
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,28390,113,0.80 [0.51-1.24],0.3090382397340683
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,28158,54,1.71 [0.91-3.20],0.0942865076100462
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,28147,43,0.86 [0.42-1.76],0.6824520888272771
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,28476,199,1.14 [0.82-1.59],0.4439865476154692
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,28594,71,2.01 [1.16-3.51],0.0134419777664361
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",28443,166,1.01 [0.70-1.45],0.9703377135451898
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,27501,77,1.06 [0.62-1.82],0.8315472104426694
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,24645,221,0.47 [0.35-0.64],9.002183644741626e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,26686,131,0.85 [0.57-1.27],0.4261067150410921
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,26699,144,0.72 [0.49-1.04],0.0781923007269303
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,24463,39,0.45 [0.22-0.90],0.0250715654917419
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,26619,72,0.76 [0.44-1.32],0.3316722446727689
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,26268,156,1.06 [0.72-1.54],0.7803280923853797
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",28528,174,0.76 [0.54-1.08],0.1277294108005532
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,28402,48,0.81 [0.41-1.59],0.5381110730889538
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,28392,38,0.90 [0.42-1.94],0.796689477780056
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,28248,1701,0.91 [0.81-1.02],0.1008476799756587
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,25687,1651,0.87 [0.78-0.98],0.0201125428806418
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",24466,42,0.72 [0.35-1.48],0.3687517738554751
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",26935,59,2.00 [1.08-3.69],0.0263976443464543
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,24619,195,0.78 [0.56-1.09],0.1423023134719167
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,24490,66,1.64 [0.91-2.95],0.0964313538711762
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,26900,2476,0.76 [0.69-0.84],1.4131543510962112e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,24547,123,0.54 [0.36-0.81],0.0031308396213989
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,24826,402,0.67 [0.53-0.84],0.0006394726661139
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,28573,283,0.66 [0.50-0.86],0.0027076448656751
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,28405,115,0.66 [0.43-1.02],0.0623233545437736
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,24525,101,0.42 [0.27-0.65],0.0001092744713773
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",24464,40,0.81 [0.39-1.71],0.5818534583663184
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,28232,1356,0.98 [0.86-1.11],0.7027584453590089
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,24555,131,0.57 [0.38-0.85],0.0053662866376091
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,24595,171,0.69 [0.48-0.98],0.0404374146755909
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",24830,406,0.71 [0.56-0.89],0.0037402864863554
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,24486,62,0.54 [0.30-0.97],0.0394179122121749
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,28398,108,0.65 [0.42-1.02],0.0600243440860135
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,24731,307,0.60 [0.46-0.78],0.0001225954182071
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,24730,306,0.67 [0.51-0.87],0.0030830051176254
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,26173,61,0.46 [0.26-0.81],0.0070989407574854
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,27961,3537,0.76 [0.71-0.83],1.8497503702141988e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,26914,38,0.55 [0.26-1.14],0.1086337175180824
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,26938,62,0.64 [0.35-1.14],0.1293928425696295
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,28486,2003,0.81 [0.73-0.90],7.60446766239761e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",28491,2001,0.81 [0.73-0.90],0.0001081027387977
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,26914,38,1.21 [0.55-2.64],0.6324825386591879
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,28343,1285,0.90 [0.79-1.02],0.1047970824496078
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",25349,925,0.60 [0.51-0.69],1.9586378536693887e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,28667,139,0.48 [0.33-0.70],0.0001402424579902
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,28389,35,0.97 [0.44-2.13],0.9415969921261031
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,27147,89,1.00 [0.61-1.65],0.9934201080273846
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,27176,118,0.73 [0.48-1.11],0.142845305352179
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",24561,137,0.69 [0.46-1.03],0.0702369579428895
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,26814,124,0.67 [0.44-1.02],0.0630577407753685
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1775,73,1.37 [0.79-2.34],0.2592372480064823
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1882,195,1.14 [0.82-1.60],0.4325075612621457
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,26732,42,0.41 [0.20-0.83],0.0127715577532376
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1740,38,0.83 [0.39-1.75],0.6183167124012936
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,28241,1551,0.58 [0.51-0.65],6.614158102947946e-20
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,28425,71,0.79 [0.45-1.37],0.3953025720914319
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,26394,282,1.08 [0.82-1.44],0.5740645751015585
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,24847,423,0.51 [0.41-0.64],3.1251349533217806e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",28586,183,0.87 [0.62-1.24],0.447764966748905
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),27919,57,0.63 [0.34-1.16],0.1393077980103326
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Angina pectoris,27355,818,0.87 [0.74-1.02],0.0905280184577036
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Aortic aneurysm,27967,105,0.99 [0.62-1.57],0.967149079217566
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,27893,31,0.91 [0.40-2.07],0.8159415133360838
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",27970,108,0.53 [0.34-0.81],0.0038270388054116
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,20460,977,0.98 [0.84-1.15],0.8249171012137408
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,AV-block,26103,192,0.73 [0.52-1.02],0.0684632217454515
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",28643,270,0.87 [0.66-1.16],0.3449304318531002
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Cardiac arrest,19601,118,0.82 [0.53-1.27],0.3782968981168594
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Cardiomyopathy,26049,138,1.15 [0.77-1.73],0.4926358300565049
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",25994,83,1.14 [0.68-1.93],0.6180968223545587
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,28679,21,0.32 [0.13-0.79],0.0139452506574796
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Conduction disorders,26463,552,0.87 [0.71-1.07],0.1816788983473585
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,27934,1408,0.89 [0.78-1.01],0.066315072258407
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,26666,6254,0.84 [0.79-0.90],2.7727223881089e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,DVT of lower extremities,27472,191,0.90 [0.64-1.26],0.5330707406242002
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Endocarditis,25957,46,1.09 [0.54-2.21],0.8020745312315143
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Heart failure, strict",28558,533,0.85 [0.69-1.04],0.1074527473131458
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Hypertension,27265,5089,0.77 [0.72-0.82],3.4816494217401548e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Hypertension, essential",27282,5106,0.76 [0.71-0.82],9.88192292016741e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Hypertension, portal",28505,60,0.90 [0.50-1.65],0.7409896833881392
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",22265,89,0.70 [0.43-1.14],0.1547673370390054
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,22240,64,0.56 [0.32-1.00],0.0519302922813999
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Hypotension,28571,716,0.68 [0.57-0.81],1.0821212266364291e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,28129,64,1.12 [0.62-2.01],0.7070747803525146
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",28099,1562,0.90 [0.80-1.01],0.0688050330137688
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",28440,317,0.65 [0.50-0.84],0.0010026289248422
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Left bundle-branch block,26111,200,0.97 [0.69-1.36],0.8603624082577217
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,28412,619,0.78 [0.65-0.94],0.0086311179708436
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",27042,505,0.83 [0.67-1.02],0.0715564641331621
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",28619,123,0.82 [0.54-1.25],0.3620428795036382
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",28662,211,0.69 [0.50-0.95],0.0240417876084944
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Oesophageal varices,27322,41,0.76 [0.37-1.59],0.4674548059562469
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other aneurysm,27914,52,1.82 [0.95-3.47],0.0701169407299577
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other arrhythmias,26161,250,1.13 [0.83-1.52],0.4421856574469738
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,27928,66,0.73 [0.41-1.27],0.2621676747322706
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,28009,147,0.83 [0.57-1.22],0.3446740887669316
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,26043,132,1.13 [0.75-1.71],0.5567782475524665
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other disorders of veins,27357,76,0.94 [0.55-1.61],0.8183877176105335
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,27331,50,0.84 [0.43-1.61],0.5918162706556818
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,27872,39,0.45 [0.22-0.92],0.0280416524082938
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,27375,94,1.01 [0.62-1.65],0.9555124249824952
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,26519,608,0.87 [0.72-1.05],0.1484414991884071
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,27903,48,0.63 [0.33-1.23],0.1772451679396147
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,28215,353,0.62 [0.49-0.79],0.000120918982384
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,28216,161,0.76 [0.53-1.09],0.131480012948816
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",28079,246,0.58 [0.44-0.78],0.0002360470073038
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,19743,260,0.98 [0.73-1.32],0.9065201117424464
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Peripheral artery disease,28049,214,0.54 [0.40-0.73],8.182372346816635e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),27545,264,0.81 [0.61-1.09],0.160997442104619
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Pulmonary embolism,28406,351,0.91 [0.70-1.16],0.4382189764253031
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,28638,343,0.75 [0.59-0.97],0.026101133784516
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Right bundle-branch block,26094,183,0.79 [0.55-1.11],0.1770343661855158
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Secondary right heart disease,28212,157,0.78 [0.54-1.12],0.1763751084411458
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,27953,120,0.52 [0.35-0.78],0.0015958329114282
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",28433,368,0.72 [0.56-0.91],0.0061489925781936
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",28406,405,0.73 [0.58-0.92],0.0071189618947252
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,28104,56,0.83 [0.45-1.53],0.5428135054786936
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,27917,56,1.32 [0.70-2.49],0.3912048721273761
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Transient ischemic attack,28271,148,0.66 [0.45-0.97],0.0340594799921366
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27978,185,0.58 [0.41-0.81],0.0014878461046731
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Varicose veins,27613,332,1.18 [0.91-1.53],0.2240125461361256
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,27871,48,0.83 [0.43-1.63],0.5939243272266632
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Venous thromboembolism,28498,552,0.83 [0.68-1.01],0.0591566391827636
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",28516,388,1.04 [0.82-1.31],0.7728324270844351
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",25569,1474,0.87 [0.77-0.99],0.0306819520801799
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Any mental disorder,27896,3801,0.84 [0.78-0.91],6.687187984934058e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",28450,460,1.05 [0.84-1.30],0.6832665025688798
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",25826,1731,0.87 [0.78-0.98],0.0165728291238126
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",24190,95,0.71 [0.44-1.14],0.1589021668084958
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Smoking dependency,28123,1573,0.71 [0.63-0.79],2.445693385264553e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",25921,1826,0.70 [0.63-0.78],2.5516869229204363e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Vascular dementia,28562,21,0.97 [0.35-2.69],0.9503487153421576
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Alzheimer disease,28679,66,0.71 [0.40-1.25],0.2347309834607971
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Bell's palsy,26953,78,0.76 [0.45-1.30],0.3163450705701904
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,27368,493,0.99 [0.80-1.22],0.8910018796608884
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Cerebral cysts,28311,212,0.83 [0.61-1.15],0.2711520917934596
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,28593,236,0.76 [0.56-1.02],0.0709582940741145
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,28534,24,0.93 [0.35-2.42],0.8769567442674143
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,28664,52,0.69 [0.50-0.95],0.0245963647239447
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",28160,61,0.63 [0.35-1.14],0.128913967809184
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Epilepsy,27046,267,0.82 [0.61-1.09],0.1662503456978275
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,28177,1398,0.86 [0.76-0.97],0.0183159689092218
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,28648,280,0.80 [0.60-1.05],0.1125134274049358
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Falls/tendency to fall,28139,1702,0.89 [0.79-1.00],0.0450594950170364
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Generalized epilepsy,28295,54,0.80 [0.43-1.50],0.4921851307711165
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Hemiplegia,28526,169,0.68 [0.48-0.96],0.0294844534899681
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Hydrocephalus,28147,48,0.73 [0.37-1.41],0.3415129355902076
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,28655,64,0.70 [0.39-1.24],0.2245478990373123
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,26958,83,0.70 [0.42-1.16],0.1645945699258035
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,26963,88,1.30 [0.79-2.13],0.3089159302653876
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Memory loss,28526,76,0.94 [0.55-1.61],0.8333221399555302
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Migraine,27220,441,1.08 [0.86-1.35],0.512579565166047
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",28585,391,1.11 [0.88-1.42],0.3777819250113533
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Motor neuron disease,20880,99,1.29 [0.80-2.08],0.2989034912123343
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,28476,149,0.72 [0.49-1.05],0.0860017810063391
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",28046,1171,0.96 [0.83-1.10],0.5194883497589875
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Neurological diseases,27197,3189,0.85 [0.78-0.93],0.000191640181004
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,28586,76,0.54 [0.32-0.90],0.0178504881700229
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",27275,400,0.90 [0.71-1.14],0.3972552153998777
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",28607,243,1.04 [0.77-1.40],0.794433589315078
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,23919,315,0.69 [0.53-0.90],0.0058065572562951
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,28161,62,0.79 [0.43-1.43],0.4291117504260855
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other disorders of nervous system,28218,119,0.61 [0.40-0.93],0.0217366126092581
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,28461,93,1.11 [0.68-1.80],0.6789298100938999
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other facial nerve disorders,26971,96,0.77 [0.48-1.23],0.271611273490243
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other headache syndromes,26842,63,0.77 [0.43-1.39],0.3844893548895883
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other neurological diseases,28553,454,0.78 [0.62-0.97],0.0229732401511057
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other sleep disorders,27386,607,0.80 [0.66-0.97],0.0249212209672275
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Parkinson's disease,28666,166,0.75 [0.52-1.08],0.1261421782433912
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,28164,65,0.72 [0.40-1.28],0.2641171180538635
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Restless leg syndrome,28678,48,1.11 [0.56-2.19],0.7599666690898803
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Sleep apnoea,28423,527,0.79 [0.64-0.96],0.0210820595480837
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Small fibre neuropathy,28401,37,1.21 [0.56-2.60],0.6328264132460887
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,28663,125,1.09 [0.71-1.66],0.6951632313097643
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,26908,33,0.82 [0.36-1.87],0.6433721522648074
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,28679,67,0.71 [0.41-1.26],0.245404319855089
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),28549,20,1.17 [0.41-3.35],0.763098504725484
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,28184,41,0.76 [0.37-1.58],0.4666115313784938
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,28317,226,0.70 [0.51-0.95],0.0238474761189783
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,28588,199,0.79 [0.56-1.10],0.1580209749186732
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,27911,38,0.73 [0.34-1.54],0.4073970210211374
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,27950,77,0.94 [0.55-1.61],0.8205090338431129
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",28585,31,0.69 [0.30-1.58],0.3785710451841321
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,28471,66,0.58 [0.33-1.01],0.0559720178764582
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1746,44,1.13 [0.55-2.29],0.7395057311657891
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2060,89,1.61 [0.99-2.61],0.0550437280239029
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,28221,78,1.11 [0.65-1.90],0.6930333242111085
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,28547,640,0.95 [0.79-1.14],0.5699789651966374
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",28365,492,0.78 [0.63-0.96],0.0210315801829739
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,28013,140,0.77 [0.52-1.15],0.2063751159793933
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",28584,493,0.85 [0.69-1.06],0.1469951450489809
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,28666,54,0.71 [0.38-1.34],0.2911835666846551
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,28509,418,0.87 [0.69-1.09],0.226015597250712
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",28635,230,0.78 [0.57-1.06],0.1156975332417269
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,28613,132,0.58 [0.39-0.86],0.0064875989907212
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,27890,17,0.52 [0.17-1.56],0.2439470952058641
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,27902,29,0.46 [0.20-1.05],0.0666733647685557
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,27905,32,0.51 [0.23-1.12],0.0935231701693787
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,28629,395,0.86 [0.68-1.08],0.1943008828271354
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,28337,103,0.82 [0.52-1.31],0.414427301845753
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,28118,27,1.73 [0.69-4.35],0.2445625202280069
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,28482,77,1.07 [0.62-1.83],0.8086286667153844
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,28559,154,0.68 [0.47-0.99],0.0423550981952501
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,28256,165,1.04 [0.72-1.50],0.8487185612820994
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,28558,77,0.58 [0.34-0.98],0.0416316232285786
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,28494,260,0.71 [0.53-0.94],0.0187611369230418
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,28265,122,0.89 [0.58-1.37],0.6068860007206853
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,27944,1092,0.82 [0.72-0.95],0.0073370845686449
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,28532,127,0.72 [0.47-1.08],0.1136079841892231
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,28652,115,0.97 [0.63-1.51],0.8955639850845619
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,28145,272,0.74 [0.56-0.98],0.0376827169199251
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,28444,39,1.05 [0.50-2.24],0.89038891579363
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,28649,37,0.85 [0.39-1.84],0.6807654136572775
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,27914,41,1.14 [0.54-2.39],0.730946677191264
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,27994,121,1.24 [0.80-1.90],0.3338435636475128
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,27979,72,0.52 [0.30-0.88],0.0148473399652014
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,28151,60,0.82 [0.45-1.50],0.5177661158987196
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",27959,52,1.23 [0.63-2.39],0.5411249191580885
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,28293,59,0.85 [0.46-1.55],0.5925052967134136
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",28329,95,0.91 [0.56-1.47],0.705576344582602
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,27966,93,0.78 [0.48-1.26],0.3067178593087901
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,28034,127,1.29 [0.84-1.97],0.2433488055868115
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,27944,37,0.75 [0.35-1.59],0.4529549570824387
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,27707,855,0.79 [0.67-0.93],0.0040276006373544
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,27922,49,0.82 [0.41-1.62],0.5639051647770941
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,28458,315,0.92 [0.70-1.20],0.5300274385769927
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,28182,39,0.88 [0.42-1.86],0.7397951904134097
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),28273,130,1.21 [0.80-1.83],0.3667961922349223
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,28477,63,0.82 [0.45-1.49],0.5168638924274156
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,28636,100,1.44 [0.90-2.31],0.1288218905123078
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,28553,140,0.69 [0.47-1.01],0.0588270830305144
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,28469,55,1.26 [0.67-2.39],0.4773773922603059
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,28470,56,0.94 [0.50-1.76],0.8357950675431551
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,28589,552,0.68 [0.56-0.83],0.00015671473235
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,28380,343,0.70 [0.55-0.90],0.0059073814864885
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,28137,100,0.72 [0.45-1.14],0.1648809872133848
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,28120,83,0.54 [0.33-0.89],0.01552572210886
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Acute pharyngitis,28383,84,0.80 [0.48-1.33],0.3956352409950925
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,28538,239,0.78 [0.58-1.05],0.1039919591773751
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,28362,63,0.62 [0.35-1.10],0.0993880109893433
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,All influenza,27319,80,1.10 [0.65-1.86],0.7286299744983336
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),27317,78,1.11 [0.65-1.89],0.6996425993301789
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Allergic asthma (mode),21255,133,0.69 [0.45-1.04],0.0761418897904728
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Allergic rhinitis,28521,321,1.03 [0.79-1.34],0.8196718053870877
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",22807,1833,0.80 [0.72-0.90],9.398438317285176e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",22924,1802,0.80 [0.71-0.89],7.621499393774226e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),28382,99,0.73 [0.46-1.15],0.1722056887155704
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",27298,59,0.59 [0.33-1.06],0.0761428891879549
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Bronchiectasis,25523,191,0.60 [0.43-0.83],0.0021536946788372
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",25376,44,0.72 [0.36-1.47],0.3684136447508847
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,27782,2450,0.77 [0.70-0.85],5.998513016985234e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",27149,69,1.13 [0.64-1.99],0.6676819983864594
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Chronic sinusitis,27255,175,1.15 [0.80-1.64],0.4543636651063732
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",28570,747,0.61 [0.52-0.72],3.235283386447669e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Deviated nasal septum,27215,135,0.55 [0.37-0.82],0.0033027371019566
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,26690,4426,0.84 [0.79-0.91],3.200683200530781e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",27473,393,0.77 [0.61-0.97],0.028110905449402
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Early onset COPD,28348,525,0.58 [0.48-0.70],2.3227755597707445e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Emphysema,25524,192,0.57 [0.42-0.78],0.0004980561357541
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,27386,119,0.52 [0.34-0.79],0.0023114358156851
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Influenza and pneumonia,28491,1252,0.75 [0.66-0.86],2.1934955272689595e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Interstitial lung disease,27412,145,0.51 [0.35-0.75],0.0005123699299351
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Later onset COPD,27192,222,0.67 [0.50-0.90],0.0078365582928585
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,28670,161,0.83 [0.57-1.19],0.3075444663861291
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Nasal polyp,27197,117,1.15 [0.74-1.78],0.5397799911253802
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,28462,641,0.72 [0.60-0.87],0.0005168705392557
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other diseases of pleura,28497,1296,0.80 [0.70-0.91],0.0005238215030536
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,27998,918,0.95 [0.81-1.11],0.496754810777578
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other pleural conditions,27236,35,0.41 [0.19-0.85],0.0172497581954358
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,28623,208,0.59 [0.43-0.81],0.0011415704502228
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,28594,881,0.78 [0.67-0.91],0.0018729389981943
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Pleural effusion,27821,620,0.80 [0.67-0.97],0.0222405445154768
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Pleural plaque,27258,57,0.52 [0.29-0.94],0.0308609431882732
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",28274,1035,0.74 [0.64-0.85],3.654516562256806e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,28649,140,0.82 [0.56-1.21],0.3226329921009857
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Pneumothorax,27266,65,0.80 [0.45-1.42],0.439929807654504
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Pollen allergy,28642,274,1.01 [0.76-1.34],0.9567034052821408
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Pulmonary oedema,28454,39,0.99 [0.47-2.09],0.9775900787418238
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Respiratory insufficiency,21160,38,0.80 [0.38-1.68],0.5536768440420258
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,28442,621,0.72 [0.60-0.86],0.0004459323975848
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,27401,321,1.03 [0.79-1.34],0.8422949345529211
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Viral pneumonia,27437,198,0.55 [0.39-0.76],0.0002777617845054
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",28402,170,0.62 [0.43-0.88],0.0078891785173905
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,16560,105,0.89 [0.56-1.43],0.63099793007401
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,21959,66,1.16 [0.65-2.07],0.6155801406161423
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Acute appendicitis,28471,163,1.32 [0.91-1.91],0.1503786452400278
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Acute gastritis,22926,75,0.74 [0.43-1.27],0.2687709647833661
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Acute pancreatitis,27025,171,0.63 [0.44-0.90],0.0106897004552435
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Acute peritonitis,28227,76,0.81 [0.47-1.38],0.431440245807597
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Alcoholic liver disease,27871,86,0.65 [0.40-1.05],0.0802791428766372
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Barrett oesophagus,23215,364,0.82 [0.64-1.06],0.1268606270065512
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",26911,57,0.74 [0.40-1.36],0.3264772775162838
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",28256,57,0.73 [0.39-1.36],0.3218218463603743
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Cholecystitis,27041,187,0.88 [0.62-1.24],0.4582100115158124
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Cholelithiasis,27793,939,0.98 [0.84-1.14],0.7740861026721322
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Chronic gastritis,23116,265,0.90 [0.67-1.21],0.480725216716786
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Chronic pancreatitis,26899,45,0.76 [0.38-1.49],0.4223833177528945
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",28526,81,1.19 [0.71-1.99],0.5212896800634532
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Coeliac disease,27203,120,1.20 [0.77-1.86],0.4118656240218834
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Collagenous colitis,27062,62,1.12 [0.61-2.05],0.7189873091749276
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,28488,215,1.10 [0.80-1.53],0.5456878779287492
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Constipation,28449,1219,0.83 [0.72-0.95],0.0061876911007673
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Crohn disease,27098,98,0.45 [0.29-0.71],0.0005592193003551
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",28320,69,0.59 [0.34-1.03],0.0620827621316941
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Crohn's disease NAS,27095,95,0.39 [0.25-0.62],4.778562819500444e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Dental caries,27809,271,0.68 [0.52-0.90],0.0066615912305456
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,26524,1892,0.87 [0.79-0.97],0.0150909677018621
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of appendix,28515,207,1.18 [0.84-1.64],0.3381304680418271
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of liver,28556,771,0.81 [0.69-0.96],0.0167290939713591
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",26909,4058,0.90 [0.84-0.97],0.0053700870685285
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",28177,639,0.86 [0.71-1.03],0.1011632843742861
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of peritoneum,28596,445,0.81 [0.65-1.02],0.0692980568283673
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,27675,137,0.94 [0.63-1.41],0.7763986062108807
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of salivary glands,27505,72,1.18 [0.68-2.06],0.5532872878226616
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of the digestive system,28391,1308,0.91 [0.80-1.03],0.1476709036164055
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of tongue,27518,126,1.01 [0.66-1.53],0.976172765290612
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",28141,1287,0.88 [0.77-1.01],0.0598225477807283
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,24427,2534,0.83 [0.76-0.92],0.0001661007104297
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Duodenal ulcer,23000,149,0.69 [0.47-1.02],0.0610949073187725
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",28606,118,0.66 [0.44-1.01],0.056914178809388
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,28537,85,0.93 [0.55-1.55],0.7685031868111273
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,27889,104,1.12 [0.71-1.77],0.6308539517750749
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,22080,187,1.14 [0.80-1.62],0.4668375562655188
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Functional dyspepsia,23385,534,0.81 [0.66-0.99],0.0438332396973532
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastric ulcer,23143,292,0.74 [0.57-0.98],0.0341519880244914
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,25190,2339,0.87 [0.79-0.96],0.0068181908952346
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,23274,423,0.74 [0.59-0.93],0.0092255303264113
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,23433,8403,0.95 [0.90-1.00],0.0353373589510649
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,GI-bleeding,28138,1055,0.95 [0.82-1.10],0.4733680081374485
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,27601,63,0.79 [0.44-1.41],0.4288883598787317
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,22854,1342,0.97 [0.85-1.10],0.6232575102023017
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",27843,58,0.95 [0.52-1.75],0.8722205150332963
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Hernia,27477,2845,0.86 [0.79-0.94],0.001126014371055
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Impacted teeth,28547,79,0.97 [0.57-1.65],0.9082733883935692
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Impaction of intestines,21927,34,0.66 [0.30-1.46],0.3057566005316341
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Inguinal hernia,25336,704,0.86 [0.72-1.02],0.0897476581647741
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",24714,82,0.80 [0.48-1.35],0.4039123269546476
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,21970,77,0.72 [0.42-1.24],0.2393851302090806
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Intestinal malabsorption,27223,140,1.17 [0.78-1.76],0.4387795948155885
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,22486,593,0.74 [0.61-0.90],0.002260584396611
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,28653,404,0.82 [0.65-1.03],0.0869321018912705
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,27728,728,0.84 [0.71-1.00],0.0565036189005999
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,27920,920,0.84 [0.72-0.98],0.0300207545238267
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Oesophageal obstruction,23009,158,1.01 [0.69-1.47],0.9699096332502268
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Oesophagitis,23356,505,0.82 [0.66-1.01],0.0584953201727981
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,28634,140,0.89 [0.60-1.33],0.5739560097926469
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,24683,51,0.67 [0.35-1.27],0.2219590813715237
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,23243,1350,0.90 [0.79-1.03],0.1288723410347689
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,27057,203,0.71 [0.51-0.97],0.0343796321324047
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,27023,169,0.85 [0.59-1.22],0.3865546687626292
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of intestine,23448,1555,0.82 [0.72-0.92],0.0008997816868615
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of intestines,26975,5082,0.87 [0.81-0.93],3.4324146829650427e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,27512,207,0.90 [0.65-1.25],0.5274881808410572
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of liver,28409,624,0.89 [0.74-1.07],0.2190070496698631
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,23412,561,0.78 [0.64-0.96],0.0157758909396155
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of pancreas,26942,88,0.91 [0.55-1.49],0.698313978807209
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,28537,386,0.78 [0.61-0.99],0.0404652627424611
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,23660,809,0.97 [0.82-1.15],0.7449831244480523
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,28152,1069,0.96 [0.83-1.11],0.5836756054167571
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,27734,196,0.91 [0.65-1.26],0.5616893248047616
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,23160,1267,0.81 [0.71-0.92],0.0014016118559349
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),24709,1858,0.87 [0.78-0.97],0.0152456746835577
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,27870,85,0.48 [0.30-0.77],0.0026439275710126
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,27805,805,0.82 [0.70-0.97],0.0236526620396755
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",22132,239,0.67 [0.49-0.90],0.0087390836510893
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,28521,100,0.85 [0.53-1.37],0.5102164218898604
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,22253,360,0.75 [0.59-0.96],0.0235341059317793
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",27224,141,0.57 [0.39-0.84],0.0040324491002385
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Recurring oral aphthae,28669,61,1.04 [0.57-1.92],0.8905508797108356
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,27556,134,0.73 [0.49-1.10],0.1292615900629487
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Toxic colitis,27033,33,0.47 [0.21-1.03],0.060697944738826
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,23042,191,0.84 [0.60-1.18],0.3116128394290484
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Ulcerative colitis,27152,152,0.88 [0.59-1.29],0.4989317215152975
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",27132,132,0.92 [0.61-1.39],0.6960172474768753
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Umbilical hernia,24921,289,0.85 [0.65-1.13],0.2674517725013984
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,21997,104,1.09 [0.68-1.72],0.7251976983784805
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Ventral hernia,24866,234,0.73 [0.54-0.99],0.0430780792842892
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Volvulus,21959,66,1.16 [0.64-2.07],0.6267815378565917
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,28621,167,0.71 [0.49-1.01],0.0590196045518826
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,28394,81,0.76 [0.45-1.28],0.3070964188636459
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,27142,153,0.88 [0.60-1.30],0.5203435718000129
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,28033,576,0.81 [0.67-0.98],0.0327842738101081
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",27663,206,0.75 [0.54-1.03],0.0772401573670132
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,27169,180,0.54 [0.39-0.76],0.0003143661064435
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,28408,238,1.07 [0.78-1.45],0.6855042875404895
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,28577,407,1.03 [0.82-1.30],0.7962877010347837
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,28218,48,1.47 [0.74-2.92],0.2710434307767609
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,27160,2686,0.94 [0.86-1.03],0.2011613881364945
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,28203,458,0.99 [0.79-1.23],0.902300935434628
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,28071,326,0.95 [0.74-1.24],0.729174896337664
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,28278,821,0.81 [0.69-0.96],0.0134591305812735
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",28665,49,0.68 [0.35-1.34],0.2665596549657034
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,27046,57,0.69 [0.50-0.96],0.0262226011873941
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,27787,42,0.98 [0.48-2.04],0.9667675973026888
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,28402,232,1.10 [0.80-1.50],0.5556863020016775
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,27291,302,1.10 [0.83-1.44],0.5164237923148497
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,27027,38,1.20 [0.56-2.60],0.6408532223402579
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,28593,71,0.59 [0.34-1.01],0.0529191840975564
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,27599,142,0.68 [0.46-1.00],0.0480723484571579
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,28476,163,1.19 [0.82-1.72],0.3496051573468712
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,28203,33,0.58 [0.27-1.28],0.1787280383613522
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,27044,55,0.88 [0.47-1.68],0.7042321743606322
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,28136,1147,0.90 [0.78-1.04],0.1462329406976163
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",27322,333,1.08 [0.83-1.41],0.5526232241036886
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,27031,42,1.17 [0.57-2.44],0.6666771616297004
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,28592,279,0.98 [0.74-1.30],0.8844188949089054
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,28234,64,0.85 [0.47-1.52],0.5807502419868715
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,28542,229,1.07 [0.78-1.46],0.6683457538496735
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,28645,191,0.75 [0.54-1.06],0.1029538731979774
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,27117,128,0.80 [0.52-1.21],0.2874303735407925
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,27185,196,1.34 [0.95-1.89],0.0915836385474644
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,28635,181,0.71 [0.50-1.00],0.0513244461538073
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",27126,137,0.85 [0.57-1.26],0.4099440291969285
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,28645,123,0.80 [0.52-1.21],0.2884943386523562
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,25175,140,1.08 [0.72-1.62],0.695936647107191
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,26782,4853,0.89 [0.83-0.95],0.0008363106833589
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,25354,3425,0.85 [0.78-0.92],5.496698917338778e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,25132,97,0.94 [0.58-1.53],0.8164453760109645
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,25738,160,0.93 [0.64-1.35],0.6964045779033895
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,25745,167,0.93 [0.64-1.34],0.6905281666800784
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,28442,120,1.18 [0.77-1.82],0.4498954805898727
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",25626,48,1.16 [0.58-2.28],0.6772781252896023
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,22713,784,0.89 [0.75-1.06],0.2034063708056596
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",28619,130,0.98 [0.65-1.48],0.9246850910923704
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,25881,303,0.78 [0.60-1.02],0.0716628244718276
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,25089,6505,0.87 [0.82-0.93],1.0302983818331198e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,27260,112,1.29 [0.83-2.03],0.2579560076935397
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,25154,119,0.94 [0.61-1.44],0.7627090831020562
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,25667,632,0.89 [0.74-1.08],0.2320697194730457
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,27755,2177,0.82 [0.75-0.91],0.0001724831855171
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,25268,233,0.97 [0.71-1.33],0.8659677831874509
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,25328,293,0.84 [0.64-1.10],0.2091532225763161
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,25189,154,0.73 [0.50-1.06],0.1003084552708248
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,28144,38,0.69 [0.32-1.49],0.3448293977528763
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,23297,1368,0.84 [0.74-0.96],0.0105734508048163
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,22344,415,1.19 [0.94-1.50],0.1470693085329606
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",28624,405,1.21 [0.95-1.53],0.1205844476153325
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,22003,74,0.67 [0.38-1.17],0.1567687533048012
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),22289,360,0.97 [0.75-1.25],0.7884126351867489
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,25379,344,1.11 [0.86-1.44],0.4119455639980849
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,22731,802,1.19 [1.00-1.41],0.0480819857619264
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,25608,30,0.48 [0.21-1.06],0.0708751499404714
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,26151,573,0.91 [0.74-1.10],0.3321171324257677
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,25871,293,0.93 [0.70-1.22],0.5960782916004277
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,22677,748,1.13 [0.95-1.34],0.1816640846806567
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,25124,89,0.63 [0.39-1.03],0.0677776962256277
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",25099,64,0.65 [0.37-1.17],0.1488693325682006
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,27208,60,0.59 [0.33-1.07],0.0844982926668741
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,28333,1185,0.78 [0.68-0.89],0.0003429719826254
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,27818,670,0.65 [0.55-0.78],2.5572399326932565e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",28567,359,0.83 [0.65-1.07],0.1444964373092022
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,23767,1838,0.81 [0.72-0.90],0.0001282593714742
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,22011,82,0.86 [0.51-1.47],0.5823652277085813
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,25117,82,1.18 [0.70-1.99],0.5330314240350664
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,21957,28,0.85 [0.35-2.08],0.7177293795465007
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),22044,115,0.71 [0.46-1.11],0.1324963515908611
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,27388,240,1.14 [0.84-1.55],0.3901234423338749
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,27397,249,0.58 [0.43-0.77],0.000206553454837
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,28637,87,1.06 [0.64-1.75],0.8304532383688844
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",27203,1625,0.82 [0.73-0.92],0.000951878320533
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,25161,126,0.75 [0.49-1.15],0.1891482172252977
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),22050,121,1.05 [0.68-1.64],0.813501179004198
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,26237,659,0.76 [0.63-0.91],0.0029356033246197
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,24059,2130,0.98 [0.88-1.08],0.6684133821622741
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,28167,61,0.87 [0.47-1.60],0.6559127514243411
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,28653,77,0.80 [0.47-1.37],0.4155204504018457
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,25121,86,1.15 [0.69-1.91],0.5903287879862809
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",26179,1144,0.86 [0.75-0.99],0.0369314411768741
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,25106,71,0.69 [0.40-1.19],0.1800825983093567
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,23097,1168,0.75 [0.65-0.86],4.033209439676662e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,27253,105,1.41 [0.89-2.23],0.145794803014803
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,25105,70,1.24 [0.70-2.19],0.4660771076391744
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,25699,121,0.69 [0.45-1.05],0.0850992177296424
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,25455,420,0.98 [0.78-1.24],0.8731270336108439
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,28323,217,0.89 [0.64-1.24],0.4921086536103169
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,26062,484,0.84 [0.68-1.04],0.1041716360724278
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,28576,339,0.79 [0.62-1.02],0.0733409188388058
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,28661,39,0.59 [0.29-1.23],0.1602514604030458
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,25251,216,1.07 [0.77-1.48],0.6802183202859127
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,23028,622,0.78 [0.65-0.95],0.0109101575060982
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,25556,521,0.77 [0.63-0.95],0.0133998133334482
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],25209,174,1.03 [0.72-1.47],0.8861141297919835
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",21966,37,0.58 [0.27-1.24],0.1584313791730395
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,23773,1844,0.86 [0.77-0.96],0.0088578215226727
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,22398,469,0.74 [0.59-0.92],0.0066275942926385
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,28195,89,0.65 [0.39-1.07],0.0891838672703898
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",28602,52,1.00 [0.52-1.91],0.9912619396626756
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",27009,31,0.90 [0.39-2.10],0.8130406243362118
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,22008,79,0.75 [0.44-1.28],0.2999279999750697
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,25672,94,0.77 [0.47-1.25],0.2874615711313005
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,22292,363,0.87 [0.68-1.12],0.2727183826929628
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,25313,278,0.96 [0.72-1.28],0.7909720414290791
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,25799,221,0.70 [0.51-0.95],0.0230799781830766
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,25688,110,0.92 [0.59-1.45],0.7267996446384413
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,24283,50,0.40 [0.21-0.76],0.0054080504612629
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",28664,42,0.55 [0.27-1.09],0.0850356668298696
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,25662,627,1.00 [0.82-1.21],0.96736507855181
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],28196,90,0.86 [0.52-1.43],0.5686036067859518
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,27546,2511,0.89 [0.81-0.98],0.0203070345350346
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",25150,115,0.98 [0.63-1.53],0.9407470317244996
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,25950,372,0.64 [0.51-0.82],0.0003145588099469
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,27233,195,0.72 [0.51-1.02],0.062816767613332
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,25734,156,0.83 [0.57-1.21],0.3395015244518466
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,26681,1103,0.70 [0.61-0.80],4.100916833904889e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,26311,733,0.67 [0.56-0.79],3.49982978122002e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],25082,47,0.79 [0.40-1.57],0.5073369074012479
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,28257,151,0.72 [0.49-1.05],0.0869870581999915
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,25198,163,0.80 [0.55-1.16],0.2470784742685319
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,25096,61,0.74 [0.40-1.35],0.3219451225632101
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),21968,39,0.92 [0.43-1.96],0.8263218517959233
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Acute renal failure,28095,892,0.78 [0.67-0.91],0.0018236327429663
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),11644,78,1.10 [0.64-1.90],0.7272410592896097
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,15476,79,0.78 [0.46-1.33],0.3623593066001772
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,28366,337,0.76 [0.59-0.98],0.0333664030248925
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,28091,62,0.55 [0.30-0.99],0.0456490734620914
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,27924,721,0.62 [0.53-0.74],8.029065711868346e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,28482,33,0.58 [0.27-1.28],0.1801873045428794
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,28496,197,0.76 [0.55-1.06],0.1085303425481238
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Cystitis,26376,167,0.63 [0.44-0.89],0.0091376673942404
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Dialysis,27265,62,0.94 [0.52-1.71],0.8318857673135307
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,12399,1176,0.91 [0.79-1.04],0.1809842614031099
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Disorders of breast,15606,209,0.77 [0.55-1.07],0.1152210488407994
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Endometriosis,11711,145,0.91 [0.61-1.36],0.651104963307248
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",11966,400,0.93 [0.73-1.19],0.5757283148593155
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,12006,440,0.72 [0.57-0.90],0.0034774736731853
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,24182,4445,0.87 [0.81-0.93],0.0001218133391527
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,28520,71,0.57 [0.33-0.98],0.043104670093019
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Hydrocele,11313,90,0.95 [0.57-1.56],0.827807074378961
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,27113,235,0.89 [0.66-1.22],0.4786892734438458
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,12002,779,0.88 [0.74-1.04],0.1353623530479827
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,15461,245,0.87 [0.65-1.18],0.3787362308774423
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),11329,106,1.14 [0.72-1.81],0.5638254485643817
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Irregular menses,15470,130,0.67 [0.45-1.02],0.0629282539764905
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Menorrhagia,11872,306,1.14 [0.86-1.51],0.3558103805051583
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,26280,71,0.94 [0.54-1.65],0.8372345847297289
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,13027,1461,0.93 [0.82-1.05],0.2458032139223888
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,11272,49,0.72 [0.37-1.41],0.3376530848967204
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,11670,104,0.92 [0.57-1.47],0.7184541354066802
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",28667,39,0.95 [0.45-2.02],0.8932777461177085
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",28674,47,0.94 [0.48-1.86],0.8605860571191416
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,27782,1573,0.85 [0.76-0.96],0.0076118460948898
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,26699,490,0.77 [0.62-0.95],0.0145092317891556
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,15467,70,0.83 [0.47-1.46],0.509994114706762
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,28627,328,0.61 [0.48-0.79],0.0001422066560097
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,11380,157,0.76 [0.52-1.11],0.1583513707983077
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,11345,122,0.98 [0.64-1.51],0.933833015315968
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,11302,79,1.13 [0.67-1.92],0.6389451750798218
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,28641,55,0.61 [0.33-1.13],0.1150662853850885
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,27346,1137,0.81 [0.71-0.93],0.003011850321076
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,15342,126,0.88 [0.58-1.35],0.5645234611227159
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,11655,89,0.58 [0.36-0.94],0.0279558922457063
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",11801,235,1.32 [0.96-1.81],0.087040798920551
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,11626,60,1.04 [0.56-1.92],0.9087918832904062
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,11674,108,1.14 [0.72-1.81],0.5817366747313216
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,27148,270,0.86 [0.65-1.15],0.3134505948111228
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,28413,114,0.42 [0.28-0.63],3.3977053763189135e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,11755,189,1.12 [0.79-1.59],0.5211884836489229
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,11650,84,0.58 [0.35-0.96],0.0327975721886368
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,12013,447,0.96 [0.77-1.21],0.7298100082535779
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,11635,69,1.13 [0.63-2.01],0.6822566361661824
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,11962,396,0.98 [0.77-1.25],0.8687230840891869
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,28499,50,0.70 [0.36-1.33],0.2728553799167796
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",11336,113,0.93 [0.60-1.47],0.7679173300835319
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,28468,1590,0.80 [0.72-0.91],0.000302371591948
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",27026,148,0.62 [0.43-0.91],0.0147335605250772
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,27283,80,0.40 [0.25-0.65],0.0002170945524936
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,28102,73,0.60 [0.35-1.03],0.063233809562196
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Urethral stricture,26385,176,1.04 [0.73-1.48],0.8405454377977546
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Urolithiasis,28430,401,0.76 [0.60-0.96],0.0225960588523766
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Uterine polyps,11674,108,1.02 [0.64-1.62],0.9282471573780988
